Cancer52 is proud to announce that it has received funding from The National Lottery Community Fund, the largest community funder in the UK. Being awarded this funding is recognition of the work achieved within and for the rare and less common cancer community, all with the shared aim of improving outcomes for patients.
From January 2024, the funding will be used alongside existing and new funding streams to allow Cancer52 to expand on three outcomes over the next three years:
Policy advances for rare and less common cancer
Addressing patient health inequalities
Therefore, the impact of this funding will be beneficial for patients, Cancer52 and its charity members, and the wider rare and less common cancer community.
Our thanks to National Lottery players!